Getting to Know Pfizer’s New Chief Medical Officer Aida Habtezion
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
Science Will WinTM
We believe science can cure every human disease. And we're going all in.
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
THE ANTIGEN: #COVID19 PODCAST
VISIT OUR COVID-19 HUB
Latest News
If approved, the vaccine would help protect adults against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, as submitted for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults…